...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Ex vivo perfusion with mitomycin C containing solution prolongs heart graft survival in rats.
【24h】

Ex vivo perfusion with mitomycin C containing solution prolongs heart graft survival in rats.

机译:含丝裂霉素C的溶液离体灌注可延长大鼠心脏移植的存活时间。

获取原文
获取原文并翻译 | 示例

摘要

Mitomycin C (MMC) is an alkylating agent which suppresses allogeneic T-cell responses. We analyzed the effect of graft perfusion with MMC on transplant survival. Hearts from Brown-Norway (BN) rats were perfused ex vivo with MMC-containing solution, stored and implanted into Lewis (LEW) rats. In order to analyze the in vivo effect of MMC, recipients received MMC posttransplantation or were pretreated with MMC-incubated donor-derived peripheral blood mononuclear cells (PBMCs). The results show that MMC-perfusion significantly prolongs graft survival. Treatment of recipients with MMC has no effect, whereas MMC-treated donor PBMCs injected into the recipient prolong graft survival. Our findings indicate that the targeted perfusion of donor hearts with MMC-containing solution protects the graft from rejection.
机译:丝裂霉素C(MMC)是一种抑制异源T细胞反应的烷基化剂。我们分析了MMC移植物灌注对移植存活的影响。用含MMC的溶液离体灌注来自Brown-Norway(BN)大鼠的心脏,保存并植入Lewis(LEW)大鼠。为了分析MMC的体内作用,受体在移植后接受MMC或接受MMC孵育的供体来源的外周血单核细胞(PBMC)预处理。结果表明,MMC灌注显着延长了移植物的存活时间。用MMC治疗受体无效果,而将MMC处理的供体PBMC注入受体可延长移植物存活。我们的发现表明,用含MMC的溶液对供体心脏进行有针对性的灌注可以保护移植物免受排斥。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号